Renal ischemia-reperfusion induces release of angiopoietin-2 from human grafts of living and deceased donors

Transplantation

Volumn 96, Issue 3, 2013, Pages 282-289

  De Vries, Dorottya K ^a   Khairoun, Meriem ^a   Lindeman, Jan H N ^a   Bajema, Ingeborg M ^a   De Heer, Emile ^a   Roest, Mark ^b   Van Zonneveld, Anton J ^a   Van Kooten, Cees ^a   Rabelink, Ton J ^a   Schaapherder, Alexander F ^a   Reinders, Marlies E J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Angiopoietins; Endothelium; Ischemia; Pericytes; Reperfusion

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; MESSENGER RNA;

ANGIOPOIETIN 1 GENE; ANGIOPOIETIN 2 GENE; ARTICLE; CELL ACTIVATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY GRAFT; KIDNEY ISCHEMIA; KIDNEY TRANSPLANTATION; LIVING DONOR; MICROVASCULATURE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN SECRETION; REPERFUSION INJURY;

ANGIOPOIETIN-1; ANGIOPOIETIN-2; HUMANS; KIDNEY; KIDNEY TRANSPLANTATION; LIVING DONORS; REPERFUSION INJURY; VON WILLEBRAND FACTOR;

EID: 84881610747     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31829854d5     Document Type: Article

References (45)

1. Dragun D, Hoff U, Park JK, et al. Ischemia-reperfusion injury in renal transplantation is independent of the immunologic background. Kidney Int 2000; 58: 2166.
2. Ojo AO,Wolfe RA,Held PJ, et al.Delayed graft function: risk factors and implications for renal allograft survival. Transplantation 1997; 63: 968.
3. Contreras AG, Briscoe DM. Every allograft needs a silver lining. J Clin Invest 2007; 117: 3645.
4. Reinders ME, Rabelink TJ, Briscoe DM. Angiogenesis and endothelial cell repair in renal disease and allograft rejection. J Am Soc Nephrol 2006; 17: 932.
5. Basile DP, Donohoe D, Roethe K, et al. Renal ischemic injury results in permanent damage to peritubular capillaries and influences long-term function. Am J Physiol Renal Physiol 2001; 281: F887.
6. Basile DP, Friedrich JL, Spahic J, et al. Impaired endothelial proliferation andmesenchymal transition contribute to vascular rarefaction following acute kidney injury. Am J Physiol Renal Physiol 2011; 300: F721.
7. Sutton TA, Mang HE, Campos SB, et al. Injury of the renal microvascular endothelium alters barrier function after ischemia. Am J Physiol Renal Physiol 2003; 285: F191.
8. Horbelt M, Lee SY, Mang HE, et al. Acute and chronic microvascular alterations in a mouse model of ischemic acute kidney injury. Am J Physiol Renal Physiol 2007; 293: F688.
9. Fiedler U, Augustin HG. Angiopoietins: a link between angiogenesis and inflammation. Trends Immunol 2006; 27: 552.
10. Smith SW, Chand S, Savage CO. Biology of the renal pericyte. Nephrol Dial Transplant 2012; 27: 2149.
11. ThurstonG, Suri C,SmithKet al. Leakage-resistant blood vessels inmice transgenically overexpressing angiopoietin-1. Science 1999; 286: 2511.
12. Maisonpierre PC, Suri C, Jones PF, et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997; 277: 55.
13. Roviezzo F, Tsigkos S, Kotanidou A, et al. Angiopoietin-2 causes inflammation in vivo by promoting vascular leakage. J Pharmacol Exp Ther 2005; 314: 738.
14. Scharpfenecker M, Fiedler U, Reiss Y, et al. The Tie-2 ligand angiopoietin-2 destabilizes quiescent endothelium through an internal autocrine loop mechanism. J Cell Sci 2005; 118: 771.
15. Woolf AS, Gnudi L, Long DA. Roles of angiopoietins in kidney development and disease. J Am Soc Nephrol 2009; 20: 239.
16. Hammes HP, Lin J, Renner O, et al. Pericytes and the pathogenesis of diabetic retinopathy. Diabetes 2002; 51: 3107.
17. Feng Y, vom HF, Pfister F, et al. Impaired pericyte recruitment and abnormal retinal angiogenesis as a result of angiopoietin-2 overexpression. Thromb Haemost 2007; 97: 99.
18. Cai J, Kehoe O, Smith GM, Hykin P, et al. The angiopoietin/Tie-2 system regulates pericyte survival and recruitment in diabetic retinopathy. Invest Ophthalmol Vis Sci 2008; 49: 2163.
19. Oh H, Takagi H, Suzuma K, et al. Hypoxia and vascular endothelial growth factor selectively up-regulate angiopoietin-2 in bovine microvascular endothelial cells. J Biol Chem 1999; 274: 15732.
20. Yuan HT, Tipping PG, Li XZ, et al. Angiopoietin correlates with glomerular capillary loss in anti-glomerular basement membrane glomerulonephritis. Kidney Int 2002; 61: 2078.
21. Tasanarong A, Khositseth S, Thitiarchakul S. The mechanism of increased vascular permeability in renal ischemic reperfusion injury: potential role of angiopoietin-1 and hyaluronan. J Med Assoc Thai 2009; 92: 1150.
22. Jung YJ, Kim DH, Lee AS, et al. Peritubular capillary preservation with COMP-angiopoietin-1 decreases ischemia-reperfusion-induced acute kidney injury. Am J Physiol Renal Physiol 2009; 297: F952.
23. de Vries DK, Lindeman JH, Tsikas D, et al. Early renal ischemiareperfusion injury in humans is dominated by IL-6 release from the allograft. Am J Transplant 2009; 9: 1574.
24. de Vries DK, Lindeman JH, Ringers J, et al. Donor brain death predisposes human kidney grafts to a proinflammatory reaction after transplantation. Am J Transplant 2011; 11: 1064.
25. Yamamoto T, Tada T, Brodsky SV, et al. Intravital videomicroscopy of peritubular capillaries in renal ischemia. Am J Physiol Renal Physiol 2002; 282: F1150.
26. Brodsky SV, Yamamoto T, Tada T, et al. Endothelial dysfunction in ischemic acute renal failure: rescue by transplanted endothelial cells. Am J Physiol Renal Physiol 2002; 282: F1140.
27. Kwon O, Hong SM, Sutton TA, et al. Preservation of peritubular capillary endothelial integrity and increasing pericytes may be critical to recovery from postischemic acute kidney injury. Am J Physiol Renal Physiol 2008; 295: F351.
28. Hattori R, Ono Y, Kato M, et al. Direct visualization of cortical peritubular capillary of transplanted human kidney with reperfusion injury using a magnifying endoscopy. Transplantation 2005; 79: 1190.
29. Schmitz V, Schaser KD, Olschewski P, et al. In vivo visualization of early microcirculatory changes following ischemia/reperfusion injury in human kidney transplantation. Eur Surg Res 2008; 40: 19.
30. Snoeijs MG, Vink H, Voesten N, et al. Acute ischemic injury to the renal microvasculature in human kidney transplantation. Am J Physiol Renal Physiol 2010; 299: F1134.
31. Satchell SC, Harper SJ, Tooke JE, et al. Human podocytes express angiopoietin 1, a potential regulator of glomerular vascular endothelial growth factor. J Am Soc Nephrol 2002; 13: 544.
32. Long DA, Woolf AS, Suda T, et al. Increased renal angiopoietin-1 expression in folic acid-induced nephrotoxicity in mice. J Am Soc Nephrol 2001; 12: 2721.
33. Xu J, Lan D, Li T, et al. Angiopoietins regulate vascular reactivity after haemorrhagic shock in rats through the Tie2-nitric oxide pathway. Cardiovasc Res 2012; 96: 308.
34. Witzenbichler B, Westermann D, Knueppel S, et al. Protective role of angiopoietin-1 in endotoxic shock. Circulation 2005; 111: 97.
35. Lee KW, Lip GY, Blann AD. Plasma angiopoietin-1, angiopoietin-2, angiopoietin receptor tie-2, and vascular endothelial growth factor levels in acute coronary syndromes. Circulation 2004; 110: 2355.
36. David S, Kumpers P, Hellpap J, et al. Angiopoietin 2 and cardiovascular disease in dialysis and kidney transplantation. AmJ Kidney Dis 2009; 53: 770.
37. Lim HS, Lip GY, Blann AD. Angiopoietin-1 and angiopoietin-2 in diabetes mellitus: relationship to VEGF, glycaemic control, endothelial damage/dysfunction and atherosclerosis. Atherosclerosis 2005; 180: 113.
38. Parikh SM, Mammoto T, Schultz A, et al. Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans. PLoS Med 2006; 3: e46.
39. Hammes HP, Lin J, Wagner P, et al. Angiopoietin-2 causes pericyte dropout in the normal retina: evidence for involvement in diabetic retinopathy. Diabetes 2004; 53: 1104.
40. Goligorsky MS, Patschan D, Kuo MC. WeibelYPalade bodiesVsentinels of acute stress. Nat Rev Nephrol 2009; 5: 423.
41. Babich V, Meli A, Knipe L, et al. Selective release of molecules from WeibelYPalade bodies during a lingering kiss. Blood 2008; 111: 5282.
42. Dong JF, Moake JL, Nolasco L, et al. ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions. Blood 2002; 100: 4033.
43. Borchiellini A, Fijnvandraat K, ten Cate JW, et al. Quantitative analysis of von Willebrand factor propeptide release in vivo: effect of experimental endotoxemia and administration of 1-deamino-8-D-arginine vasopressin in humans. Blood 1996; 88: 2951.
44. Haslinger B, Kleemann R, Toet KH, et al. Simvastatin suppresses tissue factor expression and increases fibrinolytic activity in tumor necrosis factor-alpha-activated human peritoneal mesothelial cells. Kidney Int 2003; 63: 2065.
45. Kleemann R, Verschuren L, van Erk MJ, et al. Atherosclerosis and liver inflammation induced by increased dietary cholesterol intake: a combined transcriptomics and metabolomics analysis. Genome Biol 2007; 8: R200.